Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Immuron Limited ( (AU:IMC) ) has issued an announcement.
Immuron Limited has announced the application for quotation of 135,800 fully paid ordinary securities on the Australian Securities Exchange (ASX), with an issue date of May 29, 2025. This move is part of previously announced transactions and may enhance the company’s market presence and liquidity, potentially impacting its operations and stakeholder interests positively.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 108,473
Technical Sentiment Signal: Sell
Current Market Cap: A$14.72M
Find detailed analytics on IMC stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue